...published today (I think):
Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors Usage is Associated with Improved Inflammatory Status and Clinical Outcomes in COVID-19 Patients With Hypertension
https://www.medrxiv.org/content/10.1101/2020.03.31.20038935v1